Mondrian Investment Partners LTD Sells 52,281 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mondrian Investment Partners LTD reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 397,624 shares of the company’s stock after selling 52,281 shares during the period. HCA Healthcare makes up 2.0% of Mondrian Investment Partners LTD’s investment portfolio, making the stock its 21st biggest position. Mondrian Investment Partners LTD’s holdings in HCA Healthcare were worth $127,749,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in HCA. Blair William & Co. IL raised its holdings in shares of HCA Healthcare by 11.8% during the 2nd quarter. Blair William & Co. IL now owns 9,464 shares of the company’s stock valued at $3,041,000 after buying an additional 998 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its position in HCA Healthcare by 15.0% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 26,858 shares of the company’s stock worth $8,609,000 after purchasing an additional 3,496 shares during the period. Mercer Global Advisors Inc. ADV boosted its position in HCA Healthcare by 6.4% during the second quarter. Mercer Global Advisors Inc. ADV now owns 87,444 shares of the company’s stock valued at $28,064,000 after buying an additional 5,246 shares during the period. Renaissance Technologies LLC purchased a new position in shares of HCA Healthcare in the second quarter worth about $4,112,000. Finally, Citizens Financial Group Inc. RI grew its position in HCA Healthcare by 1.0% during the 2nd quarter. Citizens Financial Group Inc. RI now owns 30,231 shares of the company’s stock worth $9,713,000 after acquiring an additional 304 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock valued at $6,407,273 over the last 90 days. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Down 1.5 %

HCA Healthcare stock opened at $397.50 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $404.90. The firm has a market cap of $104.11 billion, a price-to-earnings ratio of 19.82, a PEG ratio of 1.46 and a beta of 1.67. The stock has a fifty day simple moving average of $365.55 and a two-hundred day simple moving average of $339.06.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the company posted $4.29 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio is 13.16%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on HCA. Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Deutsche Bank Aktiengesellschaft upped their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Robert W. Baird initiated coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research report on Monday, August 19th. Finally, Oppenheimer boosted their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.